High Tide (2LYA) AI Stock Analysis

3 Followers

High Tide

(Frankfurt:2LYA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue scaling and market-share gainsHigh Tide is demonstrating broad operating momentum, with record revenue growth across its retail and medical distribution activities and share gains in key provinces. Continued expansion alongside stronger market position can improve purchasing leverage, brand visibility, and the durability of future revenue growth.

Negative Factors

Persistent losses and margin compressionHigh Tide has scaled revenue without consistently converting that growth into bottom-line profit. Persistent net losses and materially lower gross margins reduce financial resilience, limit reinvestment capacity, and make earnings improvement dependent on sustained cost control and stabilization of pricing.

High Tide (2LYA) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 225.53M
Dividend Yield: ―
Average Volume (3M): 1,368
Price to Earnings (P/E): -9.5
Beta (1Y): 0.85
Revenue Growth: 20.03%
EPS Growth: -191.94%
Country: Germany
Employees: 1,832
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Pharmaceuticals

High Tide Business Overview & Revenue Model

Company Description

High Tide Inc. operates as a prominent global player in the cannabis retail sector, with business activities spanning Canada, Europe, the United States, and other international markets. The company's portfolio is multifaceted, including the design, m...

High Tide Earnings Call Summary

Earnings Call Date:Sep 14, 2026(Q3-2026)|% Change Since:3.66%|Next Earnings Date:Apr 01, 2019

Earnings Call SentimentPositive

The call was strongly positive, with record revenue, EBITDA, operating income, net income, cash flow, customer membership, Canadian market share, and German medical cannabis volumes. Management also highlighted improving expense ratios, strong liquidity, continued organic expansion, and disciplined international growth plans. The principal challenges were Canadian consumer pressure, thinner baskets, industry competition and store growth, potential market contraction, German import quota timing, and price compression. These issues were acknowledged but did not outweigh the broad-based financial and operational momentum.

Positive Updates

Record Revenue and Broad-Based Financial Performance

Q3 revenue reached a record CAD 198.8 million, up 33% year-over-year and 11% sequentially, marking the fifth consecutive quarter with a new all-time revenue high and the fastest growth rate in 13 quarters. Both the bricks-and-mortar and medical cannabis distribution segments posted record results.

Negative Updates

Canadian Consumer Pressure and Thinner Baskets

Management said Canadian consumers are facing macroeconomic uncertainty, creeping inflation, job stress, and trade-war-related pressure. Although transaction counts increased 1.1% and customers were not leaving, customers were purchasing less per visit, including choosing ounce bags instead of 3.5-gram products.

Company Guidance

Management reiterated its long-term goal of 3 million members in Canada, plans to add 118 stores in Canada, a goal of adding 20 Cabanas during this calendar year, and a long-term target to reach 350 locations across the country; combined with Remexian’s current trajectory, this makes the company “more confident than ever” it will breach the CAD 1 billion revenue mark in the not-too-distant future. Management said Remexian will reach a higher steady state volume level than originally expected, may gain further share in Germany, and continues its march towards a 15%-20% market share in the long term; medical distribution gross margins could be “very much in the high or mid-20s going forward” and are expected to settle in the “mid to high 20s over the long term.”

High Tide Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:2LYA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:TSND	49Neutral	CAD 245.79M	-6.35	-45.81%	―	-8.14%	66.53%
TSE:WEED	46Neutral	CAD 377.68M	-1.32	-29.85%	―	10.67%	74.14%
TSE:AYR.A	40Neutral	CAD 18.10M	-0.03	-74.75%	―	―	―
TSE:JUSH	40Underperform	CAD 121.82M	-1.54	40.14%	―	5.37%	17.78%
TSE:PLTH	40Underperform	CAD 38.56M	-0.48	-131.41%	―	-21.90%	-25.05%

* Healthcare Sector Average

Performance Comparison

DE:2LYA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:2LYA	High Tide, Inc.	2.27	-0.23	-9.22%
TSE:WEED	Canopy Growth	0.88	-0.65	-42.48%
TSE:JUSH	Jushi Holdings Inc	0.61	-0.14	-18.67%
TSE:AYR.A	Ayr Wellness Inc.	0.15	0.00	0.00%
TSE:PLTH	Planet 13 Holdings, Inc.	0.12	-0.12	-52.08%
TSE:TSND	Terrascend	0.63	-0.22	-25.88%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

High Tide AI Stock Analysis